You are here: Industry Insights > COPD

News List

Trelegy Ellipta Gains Expanded COPD Indication in Europe americanpharmaceuticalreview
November 10, 2018
“We are pleased that the European Commission has approved the expanded use of Trelegy Ellipta as this will enable even more COPD patients to benefit from this important medicine,” Dr. Hal Barron, Chief Scientific Officer and President, R&D, GSK, said.
GlaxoSmithKline expands API production for COPD inhalers as Advair sales wither fiercepharma
October 24, 2018
Even with looming generic competition expected to take a big bite out of sales of its blockbuster Advair, respiratory drugs remain key to GlaxoSmithKline, and it continues to plow money into their production.
FDA Approves Stiolto Respimat sNDA to Add Data on COPD Exacerbation Reduction americanpharmaceuticalreview
October 12, 2018
Boehringer Ingelheim announced the U.S. Food and Drug Administration (FDA) approved new labeling for Stiolto Respimat (tiotropium bromide & olodaterol) Inhalation Spray that includes data showing a meaningful reduction in COPD exacerbations driven by tiot
AZ to file triple combination therapy for COPD pharmatimes
September 18, 2018
AstraZeneca has unveiled late-stage data backing use of its triple combination therapy PT010 in patients with chronic obstructive pulmonary disease (COPD).
US regulators reject GSK’s Nucala for COPD pharmatimes
September 13, 2018
GlaxoSmithKline’s bid to expand the use of its biologic Nucala in the US to include patients with coronary pulmonary obstructive disorder (COPD) has hit a significant setback.
NICE calls to limit antibiotic use in COPD over antimicrobial resistance fears pharmafile
July 17, 2018
NICE have published a draft antimicrobial prescribing guide recommending that healthcare professionals should consider the risk of antimicrobial resistance when deciding whether to prescribe antibiotics in treating chronic obstructive pulmonary disease (C
GSK picks Kevin Sim to lead business development for pharma R&D pharmatimes
July 17, 2018
GlaxoSmithKline has named Kevin Sim as senior vice president and head of worldwide business development for pharmaceuticals R&D.
GSK picks Kevin Sim to lead business development for pharma R&D pharmatimes
July 16, 2018
GlaxoSmithKline has named Kevin Sim as senior vice president and head of worldwide business development for pharmaceuticals R&D.
NICE advises restricted use of antibiotics for COPD pharmatimes
July 16, 2018
The National Institute for Health and Care Excellence is advising healthcare professionals to restrict use of antibiotics for chronic obstructive pulmonary disease (COPD).
NICE advises restricted use of antibiotics for COPD pharmatimes
July 11, 2018
The National Institute for Health and Care Excellence is advising healthcare professionals to restrict use of antibiotics for chronic obstructive pulmonary disease (COPD).

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page